Mark your calendars for 30 November at 4 PM and join us for the webinar Understanding Trabecular Meshwork Physiology and its Vital Role in Glaucoma Treatment. This session will provide an in-depth lecture on the trabecular meshwork (TM), highlighting its key function in maintaining eye pressure. We will also discuss cutting-edge glaucoma therapies that target multiple pathways, including the TM, offering new avenues for more effective treatment.
All participants of the Webinar will receive a certificate of attendance.
Not sure when the webinar takes place in your location? Click here to convert the Webinar time to your local time.
15:45 - 16:00
Video
Video
16:00 - 16:05
Introduction
16:05 - 16:20
The trabecular meshwork (TM): from tissue to function
The trabecular meshwork (TM): from tissue to function
PSProf. Carl Sheridan
16:20 - 16:35
Trabecular Meshwork- New insights from a new technique
Trabecular Meshwork- New insights from a new technique
PRProf. Aparna Rao
16:35 - 16:50
Unlocking the Potential of Targeting the Trabecular Meshwork: Novel Treatments for Glaucoma
Unlocking the Potential of Targeting the Trabecular Meshwork: Novel Treatments for Glaucoma
Glaucoma remains a leading cause of irreversible blindness worldwide, with limited advancements in topical treatments over recent years. This presentation explores innovative therapeutic strategies targeting trabecular meshwork (TM) dysfunction, which plays a critical role in maintaining intraocular pressure (IOP) and is a key contributor to glaucoma. Dysregulation of the Rho-kinase (ROCK) signaling pathway has been linked to TM dysfunction and elevated IOP. The development of ROCK inhibitors re...Glaucoma remains a leading cause of irreversible blindness worldwide, with limited advancements in topical treatments over recent years. This presentation explores innovative therapeutic strategies targeting trabecular meshwork (TM) dysfunction, which plays a critical role in maintaining intraocular pressure (IOP) and is a key contributor to glaucoma. Dysregulation of the Rho-kinase (ROCK) signaling pathway has been linked to TM dysfunction and elevated IOP. The development of ROCK inhibitors represents a promising new class of drugs with the potential to provide effective treatments for glaucoma, as demonstrated in clinical studies.view more16:50 - 17:00
Discussion and Q&A
Discussion and Q&A
All viewers can submit questions in the chat box, which will be reviewed. Only selected questions will be discussed.
